Press Releases MedMira Inc.

Equities

Market Closed - Toronto S.E. Other stock markets 20:59:59 10/05/2024 BST			5-day change	1st Jan Change
0.085 ^CAD	-5.56%		-5.56%	-22.73%

04-02	MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	CI
03-27	Samsung Pay to stop working with Russia's Mir payment system from April 3	RE

Canadian Investment Regulatory Organization Trade Resumption - MIR	31/08/23	AQ
Canadian Investment Regulatory Organization Trading Halt - MIR	29/08/23	AQ
MedMira enters into Partnership with Maternova for USA and Latin America	21/02/23	AQ
MedMira provides Progress Update	03/10/22	EQ
MedMira provides Progress Update	03/10/22	AQ
MedMira Strengthens and Expands Board	15/07/22	AQ
MedMira Reports Third Quarter Results FY2022	30/06/22	AQ
MedMira Receives Patent for its Unique Quantitative Diagnostic System	06/06/22	AQ
MedMira provides an update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market	27/05/22	AQ
VYRA™ Product Line Update	20/05/22	GL
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test	12/05/22	GL
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test	12/05/22	GL
MedMira receives the CE mark for its Reveal TP (Syphilis) and starts clinical trials in Canada	10/03/22	AQ
MedMira receives the CE mark for its Reveal® TP (Syphilis) and starts clinical trials in Canada	09/03/22	AQ
MedMira Receives CE Marking for its REVEALCOVID-19 PLUS Total Antibody Test	09/02/22	AQ
MedMira Receives CE Marking for its REVEALCOVID-19® PLUS Total Antibody Test	09/02/22	AQ
MedMira Provides a Pre-Annual General Meeting Update	04/02/22	AQ
MedMira Reports First Quarter Results FY2022	31/12/21	AQ
MedMira Announces VYRA™ CoV2Flu and Additional Regulatory Opportunities	22/12/21	AQ
MedMira strengthen its Board with New Appointment	17/12/21	AQ

No results for this search